Mandolin

Nearly every disease will become treatable in our lifetimes.

AI agents Fintech Health and bio

Latest funding

$40M Series A · June 25, 2025

Led by Greylock · Source: mandolin.com

Funding history ↓

Website: mandolin.com.

LinkedIn: withmandolin.

Categories: AI agents Fintech Health and bio.

Sectors: Artificial Intelligence (AI), Business Process Automation (BPA), Health Care, Medical.

Stage: Series A.

Based in: San Francisco, United States.

Last round: Jun 25, 2025 · 508 days ago.

On Recent Funding since: Sep 29, 2026.

Signals

Website registeredJun 20, 1997 (29 years old)

About Mandolin

Mandolin is laying the clinical and financial infrastructure to get groundbreaking treatments to patients faster, powered by AI agents. Mandolin partners closely with the largest healthcare institutions in the US, covering more than $10B drug spend across the country.

Funding rounds

Date	Round	Amount	Lead	Source
Jun 25, 2025	Series A	$40M	GGreylock	mandolin.com

Timeline

June 20, 1997
Website created

Founders and team

RR
Rohit Rustagi Founder
WY
Will Yin Founder

Investors

Companies like Mandolin

FFormation Bio$372M Series B+ · Jun 2024
TTrialSpark$156M Series B+ · Oct 2021
BBiossil$153M Seed · Sep 2026
SSoluSeries A · Apr 2025
AAmplitude Vascular SystemsSeries B+ · Feb 2025
AAlleviate Health$4.3M Seed · Oct 2025

Other companies backed by Greylock

BBlockaid$40M Series B+ · Nov 2026
SSuperMe$20M Series A · Oct 2026
WWealthsimple$425M Series B+ · Oct 2026
UUpwind$400M Series B+ · Oct 2026
SSnorkel AI$350M Series B+ · Sep 2026
HHighstock$30M Series A · Sep 2026

Greylock portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/mandolin (get a free API key).